Patient-Derived Bladder Cancer Xenografts
Patient-derived xenograft (PDX ) tumors are models developed by direct transplant of human tumors into immune-compromised hosts such as nude mice. These models retain the histological and genetic characteristics of the primary tumor and are considered a valuable platform for translational cancer res...
Saved in:
Published in | Methods in molecular biology (Clifton, N.J.) Vol. 1655; p. 169 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
2018
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Patient-derived xenograft (PDX ) tumors are models developed by direct transplant of human tumors into immune-compromised hosts such as nude mice. These models retain the histological and genetic characteristics of the primary tumor and are considered a valuable platform for translational cancer research. This chapter describes the methodology to establish and propagate bladder cancer PDX model. |
---|---|
AbstractList | Patient-derived xenograft (PDX ) tumors are models developed by direct transplant of human tumors into immune-compromised hosts such as nude mice. These models retain the histological and genetic characteristics of the primary tumor and are considered a valuable platform for translational cancer research. This chapter describes the methodology to establish and propagate bladder cancer PDX model. |
Author | Santos, Lúcio Lara Bernardo, Carina |
Author_xml | – sequence: 1 givenname: Carina surname: Bernardo fullname: Bernardo, Carina email: carinadbernardo@gmail.com, carinadbernardo@gmail.com organization: Institute for Biomedicine (IBiMED), University of Aveiro, Porto, Portugal. carinadbernardo@gmail.com – sequence: 2 givenname: Lúcio Lara surname: Santos fullname: Santos, Lúcio Lara organization: Department of Surgical Oncology, Portuguese Oncology Institute-Porto (IPO-Porto), Porto, Portugal |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28889386$$D View this record in MEDLINE/PubMed |
BookMark | eNo1zstKAzEUgOGDKPaibyDSrYvoSXImOVnqeGmhoAsFd0MySWSkTcvMKPj2Curq2_38Mzgsu5IAziReSkR75SwLKchpJ6zSJLCRdABT6QiFQeUmMBuGd0SyWtExTBQzO81mChdPfuxSGcVt6rvPFBc3Gx9j6he1L-0Pr6ns3nqfx-EEjrLfDOn0zzm83N8910uxfnxY1ddr0arKkrDZIia2nqOMmaUhlXXQlGyF2biA3vkguVLBSjScDVVtjDkHJCbZajWH89_u_iNsU2z2fbf1_Vfz_6y-ARAyQoc |
CitedBy_id | crossref_primary_10_1016_j_biopha_2022_114154 crossref_primary_10_3233_BLC_180167 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1007/978-1-4939-7234-0_14 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1940-6029 |
ExternalDocumentID | 28889386 |
Genre | Journal Article |
GroupedDBID | --- 29M 53G ACGFS ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF ECM EIF F5P NPM P2P RSU SPO UDS WH7 ZGI |
ID | FETCH-LOGICAL-c2574-7f700e87a8d1df81642f3b34e750f69b0a9ab1852b71068f645cddffb04841c32 |
IngestDate | Fri May 24 00:01:15 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Keywords | In vivo Tumorgraft Animal models Xenograft Bladder cancer Drug testing |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2574-7f700e87a8d1df81642f3b34e750f69b0a9ab1852b71068f645cddffb04841c32 |
PMID | 28889386 |
ParticipantIDs | pubmed_primary_28889386 |
PublicationCentury | 2000 |
PublicationDate | 2018-00-00 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – year: 2018 text: 2018-00-00 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Methods in molecular biology (Clifton, N.J.) |
PublicationTitleAlternate | Methods Mol Biol |
PublicationYear | 2018 |
SSID | ssj0047324 |
Score | 2.2618384 |
Snippet | Patient-derived xenograft (PDX ) tumors are models developed by direct transplant of human tumors into immune-compromised hosts such as nude mice. These models... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 169 |
SubjectTerms | Animals Antineoplastic Agents - pharmacology Disease Models, Animal Drug Evaluation, Preclinical Drug Screening Assays, Antitumor Heterografts Humans Male Mice Urinary Bladder Neoplasms - drug therapy Urinary Bladder Neoplasms - pathology Xenograft Model Antitumor Assays |
Title | Patient-Derived Bladder Cancer Xenografts |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28889386 |
Volume | 1655 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwEA9-IPgifn9LH3yRkdE2aZo8blMZYxs-bLC3kbQJCO6DMgT96700rStzivoSSlOSJr_c5e6Su0PolqaB8WOhsDBCYtjxI6A5ynAkGajPoUlSYx2ce33WHtLOKBqVudoL75KFqifva_1K_oMqvANcrZfsH5D9bBRewDPgCyUgDOWvMH5yQVHxPXT2CpJj88XykazWslBmtZGe2stXxgVrKkXQXp4zOr8GOylz49bKWEzuTNcsSjesTr1iKmha22GWzoqLIkXi7dw-Y1MR5yuia0_em43keVbrykxWjQoBrxgVtGOEwroF-EUXJadkUVRhdoFLsvKFCS_vXYB6KojAcUgoBmWDVj-HqZxPcmBC0MIFcRGxf65dCY1dVm2izZhbJte3phq3DdMYRMWKr-S637GRoIsmVrSKXLoY7KO9Qi3wGg7jA7Shp4doxyUKfTtCdytIewXSnkPaWyJ9jIaPD4NWGxdJLnAC3JLi2MS-r3kseRqkhoP2GhqiCNUgyhkmlC-FVNbDXYEsyLhhNEpSICAFrJcGCQlP0NZ0NtVnyGNKxZoIDvQXUcK1jDhnKQENXTDpc32OTt0Yx3MXyWRcjv7i25pLtLtcH1do2wDp6GuQwxbqJp_vD5ZAKgw |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patient-Derived+Bladder+Cancer+Xenografts&rft.jtitle=Methods+in+molecular+biology+%28Clifton%2C+N.J.%29&rft.au=Bernardo%2C+Carina&rft.au=Santos%2C+L%C3%BAcio+Lara&rft.date=2018-01-01&rft.eissn=1940-6029&rft.volume=1655&rft.spage=169&rft_id=info:doi/10.1007%2F978-1-4939-7234-0_14&rft_id=info%3Apmid%2F28889386&rft_id=info%3Apmid%2F28889386&rft.externalDocID=28889386 |